Simplex Trading
IGC icon

Simplex Trading’s IGC Pharma IGC Stock Holding History

Simplex Trading’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,700
Closed -$3K – 9503
2022
Q4 		$3K Sell
10,700
-1,700
-14% -$693 ﹤0.01% 8371
2022
Q3 		$5K Buy
12,400
+1,600
+15% +$852 ﹤0.01% 8772
2022
Q2 		$5K Sell
10,800
-500
-4% -$315 ﹤0.01% 8828
2022
Q1 		$10K Sell
11,300
-26,600
-70% -$25.8K ﹤0.01% 8863
2021
Q4 		$37K Sell
37,900
-14,100
-27% -$18.9K ﹤0.01% 7627
2021
Q3 		$89K Buy
52,000
+500
+1% +$808 ﹤0.01% 6785
2021
Q2 		$84K Buy
51,500
+51,017
+10,563% +$77.9K ﹤0.01% 6978
2021
Q1 		$86K Sell
483
-152
-24% -$276 ﹤0.01% 5949
2020
Q4 		$99K Buy
635
+491
+341% +$726 ﹤0.01% 5453
2020
Q3 		$14K Buy
+144
New +$146 ﹤0.01% 6605
2019
Q3 		– Sell
-215
Closed -$35K – 7525
2019
Q2 		$35K Buy
+215
New +$304 ﹤0.01% 5158

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading's IGC Position: Q4 2025 in Review

Simplex Trading sold out of IGC Pharma (IGC) in Q4 2025, closing a stake of 212 shares — an estimated $76 sold.

Simplex Trading first reported a position in IGC in Q4 2018 and held it in 20 quarters. The position peaked at $155K in Q1 2021. 30 funds tracked by Wall St. Rank hold IGC as of Q4 2025.

  • Simplex Trading reported no remaining IGC Pharma position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 212 IGC Pharma shares in Q4 2025, an estimated $76.
  • Simplex Trading first reported a position in IGC Pharma in Q4 2018 and held it in 20 quarters.
  • Simplex Trading's IGC Pharma position peaked at $155K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.